BridgeMD
New treatment option for Cervical Spinal Cord Injury
Official title Robot-assisted vs. Conventional Occupational Therapy of the Upper Limb in Individuals With Cervical Spinal Cord Injury
ClinicalTrials.gov ID: NCT06775925
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn the effects of robot-assisted therapy using the ArmeoSpring on upper limb function compared to conventional occupational therpay in individuals with cervical spinal cord injury (cSCI). The main questions it aims to answer are: \- Which of the two forms of therapy, robot-assisted therapy or conventional occupational therapy, is more effective in terms of improving arm and hand function?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Informed Consent signed by the subject
- Intermediate (\>16 days and ≤81 days post-injury) traumatic or non-traumatic cSCI during primary rehabilitation at the Swiss Paraplegic Centre (SPC)
- Neurological level of injury: C1-T1
- American Spinal Injury Association Impairment Scale (AIS): A-D
- Impairment of upper limb function (GRASSP-QtG score unilateral \< 25 at baseline t0)
You likely can't join if
- Inability to follow the procedures of the investigation
- Severe concomitant neurological disease
- Concomitant neurodegenerative or progressive diseases
- Impairment of upper limb function due to peripheral nerve lesions
- Severe concurrent medical disease or any other issue that in the opinion of the investigator would confound the results
- Orthopedic limitations of the upper limb
See the full eligibility criteria
- Informed Consent signed by the subject
- Intermediate (\>16 days and ≤81 days post-injury) traumatic or non-traumatic cSCI during primary rehabilitation at the Swiss Paraplegic Centre (SPC)
- Neurological level of injury: C1-T1
- American Spinal Injury Association Impairment Scale (AIS): A-D
- Impairment of upper limb function (GRASSP-QtG score unilateral \< 25 at baseline t0)
- Ability to sit for 60 minutes and perform training with ArmeoSpring
- Stratification parameters available
- Inability to follow the procedures of the investigation
- Severe concomitant neurological disease
- Concomitant neurodegenerative or progressive diseases
- Impairment of upper limb function due to peripheral nerve lesions
- Severe concurrent medical disease or any other issue that in the opinion of the investigator would confound the results
- Orthopedic limitations of the upper limb
- Device specific contraindications
- Participation in other treatment trials
The study team makes the final eligibility decision.
Where it's taking place
- Nottwil, Canton of Lucerne, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nottwil, Canton of Lucerne, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.